Bayesian Capital Management’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,753
Closed -$434K 970
2024
Q3
$434K Buy
+3,753
New +$419K 0.05% 406
2024
Q2
Sell
-19,232
Closed -$2.76M 1065
2024
Q1
$2.76M Buy
19,232
+14,100
+275% +$1.87M 0.26% 101
2023
Q4
$679K Buy
+5,132
New +$561K 0.07% 319
2023
Q2
Sell
-8,921
Closed -$1.56M 1034
2023
Q1
$1.56M Buy
+8,921
New +$1.5M 0.19% 154
2022
Q3
Sell
-4,275
Closed -$599K 993
2022
Q2
$599K Buy
+4,275
New +$598K 0.11% 282
2019
Q4
Sell
-4,644
Closed -$517K 736
2019
Q3
$517K Buy
+4,644
New +$503K 0.1% 270
2016
Q2
Sell
-5,744
Closed -$258K 534
2016
Q1
$258K Buy
5,744
+178
+3% +$7.66K 0.24% 203
2015
Q4
$270K Buy
+5,566
New +$275K 0.39% 119

Other funds holding SLAB

Bayesian Capital Management's SLAB Position: Q4 2024 in Review

Bayesian Capital Management sold out of Silicon Laboratories (SLAB) in Q4 2024, closing a stake of 3,753 shares — an estimated $434K sold.

Bayesian Capital Management first reported a position in SLAB in Q4 2015 and held it in 8 quarters. The position peaked at $2.76M in Q1 2024. 296 funds tracked by Wall St. Rank hold SLAB as of Q4 2024.

  • Bayesian Capital Management reported no remaining Silicon Laboratories position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 3,753 Silicon Laboratories shares in Q4 2024, an estimated $434K.
  • Bayesian Capital Management first reported a position in Silicon Laboratories in Q4 2015 and held it in 8 quarters.
  • Bayesian Capital Management's Silicon Laboratories position peaked at $2.76M in Q1 2024.
  • 296 funds tracked by Wall St. Rank held Silicon Laboratories as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.